Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.

International journal of antimicrobial agents - 1 Feb 2018

Jaidane Nadia, Naas Thierry, Mansour Wejdene, Radhia Bechir Ben, Jerbi Sofiene, Boujaafar Noureddine, Bouallegue Olfa, Bonnin Rémy A

Abstract excerpt

Acinetobacter baumannii is an opportunistic pathogen in healthcare facilities responsible for nosocomial infections mostly in immunocompromised patients. Colistin resistance is increasingly reported worldwide in A. baumannii. Here we describe the in vivo selection of colistin and rifampicin resistance in carbapenem-resistant A. baumannii. Antimicrobial susceptibility testing, plasmid analysis and whole-genome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acinetobacter baumannii
Share to Carbapenems

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colistin

Share to Disk Diffusion Antimicrobial Tests

Share to DNA-Directed RNA Polymerases

Share to Minocycline

Share to Rifampin

Share to Tigecycline

Source

Identifiers

PMID: 29127051
DOI: 10.1016/j.ijantimicag.2017.10.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.PMID 29127051Read ↗

Real-Time Sequencing To Decipher the Molecular Mechanism of Resistance of a Clinical Pan-Drug-Resistant Acinetobacter baumannii Isolate from Marseille, FranceSemantic proximity Read ↗

Whole-Genome Sequencing of a Colistin-Resistant Acinetobacter baumannii Strain Isolated at a Tertiary Health Facility in Pretoria, South AfricaSemantic proximity Read ↗

A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.Semantic proximity Read ↗

Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolatesSemantic proximity Read ↗

Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumanniiSemantic proximity Read ↗

Comparative genotypic characterization related to antibiotic resistance phenotypes of clinical carbapenem-resistant Acinetobacter baumannii MTC1106 (ST2) and MTC0619 (ST25).Semantic proximity Read ↗

WGS based analysis of acquired antimicrobial resistance in human and non-human Acinetobacter baumannii isolates from a German perspective.Semantic proximity Read ↗

Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.Semantic proximity Read ↗

Molecular Characterization of Carbapenem/Colistin-Resistant Acinetobacter baumannii Clinical Isolates from Egypt by Whole-Genome SequencingSemantic proximity Read ↗

Acinetobacter baumannii Antibiotic Resistance MechanismsSemantic proximity Read ↗

Subtypes, resistance and virulence platforms in extended-drug resistant Acinetobacter baumannii Romanian isolatesSemantic proximity Read ↗

Comparative genomic analysis of Acinetobacter baumannii clinical isolates reveals extensive genomic variation and diverse antibiotic resistance determinants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.